Assoc. Prof. Dr. Sherif Shawky , Misr Univeristy For Science and Technology , EgyptĀ
Assoc. Prof. Dr. Sherif Shawky is an expert in cell biology, nanobiotechnology, and molecular diagnostics. With a background in pharmacy and biotechnology, he has held faculty and research positions at leading institutions, including the University of Connecticut, Misr University for Science and Technology, and Zewail City of Science and Technology. His work focuses on CRISPR-based assays, nanoparticles, and microfluidic platforms for early disease detection, particularly for cancers, viral infections, and neurodegenerative diseases. Dr. Shawky has been involved in numerous research projects and has contributed significantly to both academia and entrepreneurship. He has been awarded prestigious fellowships, including the Royal Academy of Engineering’s Leaders Innovation Fellowship, and has mentored many students and professionals in the field.
Professional Profile:
Google ScholarĀ
Summary of Suitability for Award:
Assoc. Prof. Dr. Sherif Shawky is highly suitable for the “Best Researcher Awards” due to his remarkable contributions to the fields of cell biology, nanobiotechnology, and molecular diagnostics. He holds a Ph.D. in Cell Biology and Nanobiotechnology from Erasmus University Rotterdam, Netherlands, and has an extensive background in the development of advanced diagnostic tools, specifically focusing on diseases like Hepatitis C, Alzheimerās, and various types of cancer. His innovative work in the design and application of nanomaterials, including nanoparticles (such as silica, gold, magnetic, and carbon dots), in biosensors and point-of-care diagnostic devices has had a significant impact on early detection and quantification of biomarkers related to cancer, liver diseases, and neurodegenerative conditions.
šEducation:
Assoc. Prof. Dr. SherifĀ ShawkyĀ earned his Ph.D. in Cell Biology and Nanobiotechnology from Erasmus University Rotterdam, Netherlands . He also holds a Masterās in Biomolecular Sciences from the Free University Amsterdam, specializing in Molecular Cell Biology . He completed his Bachelor of Pharmacy at Misr University for Science and Technology, Egypt. His academic journey has been marked by significant research contributions in the areas of molecular diagnostics, drug delivery, and biosensors, culminating in innovative diagnostic technologies.
š¢Work Experience:
Assoc. Prof. Dr. SherifĀ ShawkyĀ has extensive experience as a Research Assistant Professor at the University of Connecticut (UCONN), working on CRISPR-based assays for Alzheimerās disease diagnosis. He is an Associate Professor of Biochemistry and Entrepreneurship at Misr University for Science and Technology, where he focuses on the development of smart drug delivery systems. His postdoctoral work at Zewail City involved pioneering nanoparticle-based assays for the detection of viral RNA and cancer biomarkers. He is also a Visiting Scholar at Zewail City, where he leads cutting-edge diagnostics projects.
š
Awards:
Assoc. Prof. Dr. SherifĀ ShawkyĀ has received several prestigious awards for his research and entrepreneurial initiatives. He was selected as a Fellow by the Royal Academy of Engineering, where he also secured second place in the final pitch of the Leaders Innovation Fellowship. His entrepreneurial skills were further recognized when he won first place in the final pitch of the Innovate Egypt Program, a joint initiative by VENTUREWELL, USAID, and the National Academy of Science. Shawkyās innovative contributions have also earned him a mentorship role in various incubators and pre-incubators in Egypt, where he guides aspiring entrepreneurs. He has been recognized for his work in disability inclusion and reducing inequalities in healthcare. These honors highlight his excellence in both scientific research and entrepreneurial ventures, showcasing his commitment to advancing health technologies, biosensors, and nanotechnology. Shawky’s multifaceted work continues to have a lasting impact in both academia and industry.
š¬Research Focus:
Assoc. Prof. Dr. SherifĀ ShawkyĀ research focuses on the development of nanotechnology-based diagnostic tools for early disease detection, particularly for cancers, viral infections, and neurodegenerative diseases. He specializes in CRISPR/Cas technology, nanoparticle synthesis, and microfluidic chip design. His work on integrating nanoparticles with electrochemical, fluorescence, and colorimetric techniques has led to innovative point-of-care devices for viral RNA quantification and cancer biomarkers. His efforts aim to revolutionize diagnostic technologies for clinical applications.
Publication Top Notes:
-
Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles
-
Nucleic acids biosensors based on metal-organic framework (MOF): Paving the way to clinical laboratory diagnosis
-
Gold aggregating gold: a novel nanoparticle biosensor approach for the direct quantification of hepatitis C virus RNA in clinical samples
-
A novel HCV electrochemical biosensor based on a polyaniline@Ni-MOF nanocomposite
-
A novel Ag/Zn bimetallic MOF as a superior sensitive biosensing platform for HCV-RNA electrochemical detection